Top Markets
Coin of the day
Spago Nanomedical AB (publ) Spago Nanomedical AB (publ)

Spago Nanomedical AB (publ)

SPAGO
Pozycja w akcjach #32286
Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to... Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to pioneering nanomedicines for both the diagnosis and treatment of cancer. The company is actively pursuing two key projects: the SpagoPix initiative, centered on SN132D, a gadolinium-free MRI contrast agent developed for imaging breast and pancreatic cancers; and the Tumorad project, which is advancing SN201, a radionuclide therapy intended for managing advanced and metastatic forms of cancer. Originally established as Spago Imaging AB (publ), the company adopted its current name, Spago Nanomedical AB (publ), in May 2014. Founded in 1999, its base of operations is situated in Lund, Sweden.
Cena akcji
$0.01317984
Ostatnia synchronizacja: 2026-08-17
Kapitalizacja rynkowa
$10.52M
Zmiana (1 dzień)
-1.26%
Zmiana (1 rok)
-53.51%
Kraj
SE
Handel Spago Nanomedical AB (publ) (SPAGO)

Kategoria

Historia stopy dywidendy dla Spago Nanomedical AB (publ) (SPAGO)
Stopa dywidendy (TTM) dla Spago Nanomedical AB (publ) (symbol akcji: SPAGO) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Spago Nanomedical AB (publ) (SPAGO) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji